Phase 3 GLOW: first-line ibrutinib plus venetoclax improves outcomes in elderly or unfit CLL physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.